Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NMES for Achilles Tendon Rupture

NCT: NCT04727047 · TERMINATED

NCT IDNCT04727047
StatusTERMINATED
Start Date2023-02-15
Completion2024-12-31
SponsorPenn State University (OTHER)
First posted
Last updated

Brief Summary

The majority of patients suffering an Achilles tendon rupture develop long term functional deficits in the affected leg. The goal of the proposed study is to evaluate a new rehabilitation protocol using Neuromuscular Electrical Stimulation (NMES) for reducing muscle atrophy and improving tendon properties. If proven beneficial, the proposed protocol can be easily adopted and incorporated as part of routine care for Achilles tendon rupture.

Frequently Asked Questions

What is NMES for Achilles Tendon Rupture?

NMES for Achilles Tendon Rupture is a clinical trial registered under NCT04727047. Current status: TERMINATED.

What is the status of NCT04727047?

The current status of NCT04727047 (NMES for Achilles Tendon Rupture) is: TERMINATED.

When did NMES for Achilles Tendon Rupture start?

NMES for Achilles Tendon Rupture started on 2023-02-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.